logo
AI Icon𝛼SK or Search
ENTITY
Mega Lifesciences

Mega Lifesciences (MEGA TB)

83
Analysis
Health Care • Thailand
Mega Lifesciences is a leading international pharmaceutical and nutraceutical company that manufactures, markets, sells, and distributes quality pharmaceutical products, medicinal supplements, and personal health products. The company also operates through its branded products segment, Mega We Care, and a distribution platform, Maxxcare, for third-party products. It is headquartered in Bangkok, Thailand, and was founded in 1982.
more
bullish•Mega Lifesciences
•18 Aug 2022 11:18•Broker

MEGA : Strong Performance Amid Uncertainty

Downgrade our recommendation from BUY to HOLD with a target price of Bt54. Despite the challenges in Myanmar. MEGA reported 2Q22 net profit of...

Logo
Share
bullish•Mega Lifesciences
•05 Jan 2022 10:33•Broker

MEGA: Expect Growth Rate to Slow Down in 2022

We maintain BUY rating and roll over target price to Bt56 (+8% from previous TP) based on 25xPE’22E, a 15% discount from Thai health care peers.

Logo
Share
bearish•Mega Lifesciences
•19 Dec 2018 06:27

Small Cap Diary: MEGA, Eastwater

Small caps have an easier time scaling up in good times, but can get hit much harder by liquidity in the bear markets. Anyway, it's still good to...

Logo
Share
bullish•Mega Lifesciences
•19 Nov 2018 14:44•Broker

MEGA: 3Q18 Result Is Slightly Below Our Expectation

MEGA reported 3Q18 net profit of Bt255m (+4%YoY, -12%QoQ). 9M18 result accounts for 63% of our full year forecast and is slightly below our...

Logo
Share
bullish•Golden Lime
•18 Sep 2018 23:16

SUTHA: Growing Quick Lime Via Acquisitions & Expansion

We first heard about this for the first time when the same tycoon (Nishita Shah Federbush) who controls Mega Lifesciences (MEGA TB), a top five...

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5

x